Sunday, December 22nd, 2024

Day: December 11, 2024

Clearbridge Health Limited Completes Rights Issue: 1.24 Billion New Shares to Begin Trading on SGX Catalist

Clearbridge Health’s Major Share Expansion: What Investors Need to Know Clearbridge Health’s Major Share Expansion: What Investors Need to Know Clearbridge Health Limited has announced a significant development in its capital structure through a...

Clearbridge Health Announces S$2.56 Million Rights Issue to Strengthen Financial Position and Fuel Growth

Clearbridge Health’s Massive Rights Issue: A Game-Changer for Shareholders? Clearbridge Health’s Massive Rights Issue: A Game-Changer for Shareholders? Clearbridge Health Limited has announced a significant financial maneuver with its proposed renounceable non-underwritten rights issue,...

Clearbridge Health Limited Announces Non-Underwritten Rights Issue: Key Details for Shareholders

Clearbridge Health’s Strategic Rights Issue: A Financial Game-Changer Clearbridge Health’s Strategic Rights Issue: A Financial Game-Changer Clearbridge Health Limited is making a bold move with its recent announcement of a Rights Issue, which could...

Clearbridge Health Announces Key Dates for 1.28 Billion Share Rights Issue

Clearbridge Health’s Strategic Rights Issue: A Closer Look at Shareholder Opportunities Clearbridge Health’s Strategic Rights Issue: A Closer Look at Shareholder Opportunities Clearbridge Health Limited has announced a proposed renounceable non-underwritten rights issue, aiming...

Clearbridge Health Receives SGX-ST Approval for Massive 1.28 Billion Rights Share Issuance

Clearbridge Health’s Strategic Share Issue: A Potential Game Changer for Investors Clearbridge Health’s Strategic Share Issue: A Potential Game Changer for Investors Clearbridge Health Limited, a prominent player in Singapore’s healthcare sector, has announced...

Clearbridge Health Announces Record Date for Rights Issue: Key Details for Shareholders

Clearbridge Health Rights Issue: What Shareholders Need to Know Clearbridge Health Rights Issue: What Shareholders Need to Know Clearbridge Health Limited has announced a proposed renounceable non-underwritten rights issue of up to 1,279,125,560 new...

Silverlake Axis Goes Private: A Game-Changing Dual-Pricing Strategy Shakes Up the Market

  Silverlake Axis, a Singapore-listed technology solutions provider, has turned heads with its innovative privatisation strategy. The deal, spearheaded by founder Goh Peng Ooi and private equity firm Ikhlas Capital, leverages a unique dual-pricing...

“Telcos on the Edge: Why Consolidation Won’t End Singapore’s Mobile Price Wars”

Singapore’s telco industry is facing intense competition as aggressive pricing wars continue to erode mobile revenue, leaving industry players scrambling for innovative solutions. While a potential merger between StarHub and M1 could reduce the...

Reviving Orchard Road: Ong Beng Seng’s Hotel Properties’ Redevelopment Could Be a Game-Changer

  Orchard Road, Singapore’s iconic shopping belt, stands at a crossroads. While festive lights and luxury brands draw crowds, the area faces stiff competition from suburban malls, online shopping, and regional retail hubs. Embattled...

Key Insights on Sunpower Group’s S$99.6M Convertible Bond Rights Issue

Sunpower Group’s announcement of a S$99.6M convertible bond rights issue is a corporate action designed to raise funds by issuing convertible bonds to its existing shareholders. Here’s how it works and what it means...